InvestorBrandNetwork (IBN) Content Platform

Superior Group of Companies (NASDAQ: SGC), established in 1920, is a combination of companies that help their customers unlock the power of their brands by creating extraordinary brand engagement experiences for their employees and customers. SGC’s commitment to service, technology, quality and value-added benefits, as well as its financial strength and resources, provides unparalleled support for its customers’ diverse needs while embracing a “Customer 1st, Every Time!” philosophy and culture in all of its business segments. For more information, visit the company’s website at www.superiorgroupofcompanies.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Pineapple Energy (NASDAQ: PEGY) is focused on growing leading local and regional solar, storage, and energy services companies nationwide. Our vision is to power the energy transition through grass-roots growth of solar electricity paired with battery storage. Our portfolio of brands (SUNation, Hawaii Energy Connection, E-Gear, Sungevity, and Horizon Solar Power) provide homeowners and small businesses with an end-to-end product offering spanning solar, battery storage, and grid services. For more information, visit the company’s website at www.pineappleenergy.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a proprietary SaaS technology company delivering mobile live dealer technology to online gaming operators globally, is reporting on its financial and operational performance for the fiscal year ending Dec. 31, 2022. Financial highlights include revenues of CAD$957,745 from its Live Dealer platform, a 500% increase from the previous year; total wagering turnover for the year reached CAD$926.75 million, an increase of 300% from the previous year; total wager activity, or betspots, numbered 27.1 million bets, compared to 4.4 million bets during FY 2021; average daily turnover for FY 2022 came in at CAD$2.54 million, an increase of 180% over 2021; and average monthly player activity for the period was 17,820 compared to 7,200 during the year ended Dec. 31, 2021, a 150% increase. In addition, corporate highlights included the company’s announcement that it had applied for a Gaming Related Supplier — Manufactures License with the Alcohol and Gaming Commission of Ontario (the “AGCO”) and signed a software licensing and distribution agreement with Markor Technology, for Markor to add and market Playgon’s proprietary mobile first live dealer and E-table game offerings to its content library. The company also received certification for live dealer studio in accordance with GLI-19, Isle of Man, and Ontario technical requirements and signed a multijurisdictional software license and distribution agreements with global iGaming aggregator Pariplay Limited and EveryMatrix Software Ltd. In addition, the company noted that on Jan. 19, 2023, it closed a nonbrokered private placement of unsecured convertible debentures for gross proceeds of $2,095,000.

To view the full press release, visit https://ibn.fm/GB4tk

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Limbach Holdings (NASDAQ: LMB) is a building systems solutions firm with expertise in the design, prefabrication, installation, management and maintenance of heating, ventilation, air-conditioning (“HVAC”), mechanical, electrical, plumbing and controls systems. With over 1,500 team members and 17 offices located throughout the United States, we partner with institutions with mission-critical infrastructures, such as data centers and healthcare, industrial & light manufacturing, cultural & entertainment, higher education, and life science facilities. With Limbach’s full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, Limbach is positioned as a value-added and indispensable partner for building owners, construction managers, general contractors, and energy service companies. For more information, visit the company’s website at www.limbachinc.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

Limbach Investor Relations

The Equity Group, Inc.

Jeremy Hellman, CFA

Vice President

(212) 836-9626 / [email protected]

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Jasper Therapeutics (NASDAQ: JSPR) is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic for chronic mast and stem cell diseases such as chronic urticaria and lower to intermediate risk myelodysplastic syndromes (“MDS”) and as a conditioning agent for stem cell transplants for rare diseases such as sickle cell disease (“SCD”), Fanconi anemia (“FA”) and severe combined immunodeficiency (“SCID”). To date, briquilimab has a demonstrated efficacy and safety profile in over 130 dosed subjects and healthy volunteers, with clinical outcomes as a conditioning agent in SCID, acute myeloid leukemia (“AML”), MDS, FA, and SCD. In addition, briquilimab is being advanced as a transformational non-genotoxic conditioning agent for gene therapy. For more information, visit the company’s website at www.jaspertherapeutics.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Advantage Communications Group (Advantage) has achieved status as an ISO/IEC 27001:2013 certified provider. The company announced that its Information Security Management System (“ISMS”) has earned third-party certification from the International Standards Organization (“ISO”). According to the announcement, ISO/IEC 27001:2013 is an information security management system standard published in October 2013 by the International Organization for Standardization and the International Electrotechnical Commission (“IEC”). In order to earn the key certification, Advantage partnered with A-LIGN, an independent third-party auditor and ISO/IEC 27001 certification body to conduct the certification process and verify that Advantage has key technical controls and IT Security policies and procedures in place. “This certification ensures our clients that the security of their data and information has been addressed, implemented, and properly controlled in all areas of our organization,” said Advantage Communications Group CEO David Gardner in the press release. “As the first global, full-lifecycle telecom MSP providing communications and technology solutions to more than 1,400 enterprises worldwide, Advantage takes threats to the availability, integrity and confidentiality of its clients’ information seriously. This accomplishment exemplifies our commitment to empowering organizations with reliable, vetted telecom solutions from a worldwide network of service providers for whom security is of paramount importance. This certification [also] ensures our clients that the security of their data and information has been addressed, implemented and properly controlled in all areas of our organization.”

To view the full press release, visit https://ibn.fm/6Vssm

About Advantage Communications Group

Advantage Communications Group is a strategic partner that employs a unique, holistic approach to technology lifecycle optimization that reduces costs, complexity and administrative burdens through each phase of the tech journey. For enterprises in markets that demand persistent connectivity, cybersecurity, high-speed data and network infrastructure, Advantage is a global, telecom MSP with the expertise, services portfolio and worldwide partner network to design, deploy and manage IT and telecom environments from end-to-end. For more information about this company, visit www.AdvantageCG.com

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideal Power (NASDAQ: IPWR) is pioneering the development of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN(TM)) semiconductor technology. B-TRAN(TM) is a unique double-sided bidirectional AC switch able to deliver substantial performance improvements over today’s conventional power semiconductors. Ideal Power believes B-TRAN(TM) will reduce conduction and switching losses, complexity of thermal management and operating cost in medium voltage AC power switching and control circuitry. For more information, visit the company’s website at www.IdealPower.com, on LinkedIn, on Twitter, and on Facebook.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

BioRestorative Therapies (NASDAQ: BRTX) (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:

• Disc/Spine Program (brtxDISC(TM)): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

• Metabolic Program (ThermoStem(R)): We are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes. For more information, visit the company’s website at www.biorestorative.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced the pricing of a $14.3 million private placement of convertible preferred stock. The announcement noted that the placement had been priced at the market under NASDAQ rules and included “significant participation by select members of leadership, the board and existing investors.” In addition, DarioHealth also noted that it had refinanced $25 million in borrowed funds, saving approximately $6 million in annual amortization payments. “These actions are very positive for Dario as they provide an additional year and a half of cash runway, based on our current operating plan, at terms that I believe are very favorable to our company,” said DarioHealth CEO Erez Raphael in the press release. “We are delighted that approximately half of the newly designated convertible preferred shares, which were priced at the market under NASDAQ rules, were purchased by select members of the company’s leadership, the company’s board of directors, and existing shareholders, which we view as an additional vote of confidence. Additionally, the refinancing of our existing credit facility will save approximately $6  million annually in amortization expenses. This financing will help us to continue to execute on our long-term growth strategy, which is focused exclusively on high margin, highly scalable business-to-business customer channels and allow us to maintain these positive trends in the future.”

To view the full press release, visit https://ibn.fm/FgYsY

About DarioHealth Corp.

DarioHealth Corp. is a leading DTx company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, has entered into a distribution agreement with Stein Distributing; the agreement outlines the distribution of all four Splash brands in the state’s largest city and capital: Boise. Founded more than 60 years ago, Stein Distributing is a premier distributor in Idaho that carries brands from the Anheuser-Busch portfolio. The company services an area that covers more than 30,000 square miles in 10.5 counties and serving a population of more than 700,000 people. “This agreement with yet another strong Anheuser Busch distributor gives us a strong foothold in Idaho’s capital and most populous city,” said Splash Beverage CEO and chair Robert Nistico in the press release. “Our agreement calls for the distribution of all four Splash brands and with Stein’s commitment to excellence and deep roots in Idaho, we are confident we’ll see strong growth in all four brands.”

To view the full press release, visit https://ibn.fm/yJO4d

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and nonalcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com. 

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PowerTap’s (NEO: MOVE) (OTC: MOTNF) (FWB: 2K6) wholly owned subsidiary, PowerTap Hydrogen Fueling Corp., today provided an update on its efforts with Newport Realty Group on a planned cutting-edge fueling station in East San Bernardino County, California, as announced in a press release on April 3, 2023. Subject to applicable permits and sufficient financing, the station will offer PowerTap hydrogen onsite production/dispensing, battery electric charging and petrol options to meet the growing demand for sustainable transportation solutions. “We are excited to be involved in this cutting-edge project that combines hydrogen, battery electric charging and petrol options in a single fueling station,” said Salim Rahemtulla, president and CEO of PowerTap Hydrogen Fueling Corp. “By utilizing fuel cells to generate clean electricity from hydrogen, we can provide a sustainable and cost-effective solution for powering the EV charging stations and building loads at the site, reducing the reliance on grid power and minimizing the overall carbon footprint.”

To view the full press release, visit https://ibn.fm/w9iV9

About PowerTap Hydrogen Capital Corp.

PowerTap Hydrogen Capital Corp., through its wholly owned subsidiary, PowerTap Hydrogen Fueling Corp. (“PowerTap”), is focused on installing hydrogen production and dispensing fueling infrastructure in the United States. PowerTap’s patented solution has been developed over 20 years. PowerTap is now commercializing its third-generation blue hydrogen product that will focus on the refueling needs of the automotive and long-haul trucking markets that lack hydrogen fueling infrastructure. For more information about the company, visit www.PowerTapcapital.com and www.PowerTapfuels.com.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Agenus (NASDAQ: AGEN) is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer and infections. The company’s vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its subsidiary MiNK Therapeutics), and adjuvants (through its subsidiary SaponiQx). The company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, visit the company’s website at www.agenusbio.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

To contact the company’s Investor Relations department please email [email protected]

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has filed a Technical Report Summary (“TRS”) outlining updated mineral resources for its wholly owned Roughrider Project. The project is a conventional uranium project located in the eastern Athabasca Basin of northern Saskatchewan, Canada, recognized as one of the world’s premier uranium mining jurisdictions. According to the report, the total Roughrider Project resources are 27.8 million pounds U3O8 in 389,000 tonnes grading 3.25% U3O8 in the indicated category and 36.0 million pounds U3O8 in 359,000 tonnes grading 4.55% U3O8 in the inferred category. The company noted that it had partnered with SRK Consulting to prepare the TRS resource report. UEC also reported that it anticipates next steps regarding the project will be to commission an initial assessment economic study and complete further delineation drilling to upgrade the current inferred resources to indicated. “Our vision is to develop UEC as the leading Western supplier of secure, 100% unhedged uranium, combining a platform of U.S. and Canadian assets,” said Uranium Energy CEO and president Amir Adnani in the press release. “The new Roughrider resource is an exciting catalyst for UEC in Eastern Athabasca and anchors our Canadian high-grade conventional pipeline. From here, we’re gearing-up to 1) complete an Initial Assessment economic study at Roughrider and 2) conduct additional drilling to enhance and grow this latest resource. Our future development plans will substantially benefit from the tier one ESG, geotechnical and permitting work completed by Rio Tinto to advance the Roughrider Project towards production.”

To view the full press release, visit https://ibn.fm/aU8PA

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel required for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly, in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in south Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Infobird (NASDAQ: IFBD), a software-as-a-service provider of AI-powered customer engagement solutions in China, announced it has filed its annual report on Form 20-F for the fiscal year ended Dec. 31, 2022, with the U.S. Securities and Exchange Commission (“SEC”). The report, which contains Infobird’s audited consolidated financial statements for the fiscal year ended Dec. 31, 2022, can be accessed through the SEC’s website or Infobird’s website. In addition, Infobird will provide a hard copy of its annual report containing audited consolidated financial statements free of charge to its shareholders upon request. Requests should be directed as detailed in the announcement.

To view the full press release, visit https://ibn.fm/LqJfY

About Infobird Co. Ltd.

Infobird, headquartered in Beijing, China, is a software-as-a-service provider of innovative AI-powered, or artificial intelligence-enabled, customer engagement solutions. For more information, visit Infobird’s website at www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, today announced that it will release its 2023 first quarter financial results after the market closes on Wednesday, May 10, 2023. At 5:00 p.m. ET on that same day, the company will host a conference call and simultaneous webcast, which will be open to the general public. On the call, DoubleDown management will host a presentation followed by a question-and-answer period. Interested parties should visit https://ibn.fm/8GsWL to register, after which an email will be sent, including dial-in details and a unique conference call access code required to join the live call. Attendees are asked to register a minimum of 15 minutes before the start of the call to ensure connection.

To view the full press release, visit https://ibn.fm/QOQ2b

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. Its flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global (OTCQB: SHRG) and DSS Inc. (NYSE American: DSS) have announced the distribution date for the common stock of Sharing Services Global Corporation that is beneficially held by DSS directly and through its subsidiary, Decentralized Sharing Systems Inc. (“DSSI”). According to the announcement, each share of DSS common stock outstanding as of 5 p.m. ET held on April 28, 2023, will entitle the holder to receive two SHRG common stock shares to be distributed on May 4, 2023. DSS is a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs. Sharing Services is a diversified direct-marketing company. When the distribution is complete, DSS and DSSI will have an approximate 7% ownership interest in Sharing Services Global Corporation.

To view the full press release, visit https://ibn.fm/FsaBx

About Sharing Services Global Corporation

Sharing Services Global Corporation is a publicly traded company dedicated to building shareholder value by developing or acquiring businesses, products and technologies in the direct-selling industry and other industries that augment the company’s product and services portfolio, business competencies, and geographic reach. The company’s primary growth strategy is built on focused innovation and creativity positioned to capture profitable market share of diverse business models. For more information, please visit the company’s website at www.shrginc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, today announced the engagement of Kingswood, a division of Kingswood Capital Partners. According to the update, Kingswood will serve as the company’s placement agent and advisor in connection with the planned spin-off of coyni, a wholly owned subsidiary of RYVYL, and subsequent public offering. The planned, approximately $40 million offering with a NASDAQ uplisting is based on an estimated valuation of $200 million for coyni’s assets and merging of other revenue sources. RYVYL has not obtained an independent third-party valuation of coyni. The company is evaluating additional details regarding the spin-off and offering and will provide further information when available.

To view the full press release, visit https://ibn.fm/cCY19

About RYVYL Inc.

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017 in San Diego, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection, and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information, visit www.RYVYL.com

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep issues arising from certain dentofacial abnormalities, is reporting on the results of a recent clinical observational study. According to the announcement, the study evaluated the application of Vivos’ recently acquired Preventive Oral Device(R), known as the POD(R), in the treatment and prevention of migraine headaches. In its report, the company noted that the study “demonstrated statistically significant results.” The report noted that 92% of study participants reported their migraine symptoms were completely resolved following completion of treatment, with those results being maintained from 3 to 28 months after treatment began. The study assessed the severity of the migraines by using the validated Migraine Disability Assessment Questionnaire (“MIDAS”). Before treatment, participants reported an average MIDAS score of 23.96 +/- 21.34; following treatment; they reported MIDAS scores of 2.58 +/- 4.87, a reduction of 89.2%. “For the tens of millions of patients right here in the U.S. who suffer from migraines, we believe our new POD treatment option has the potential to be game changer,” said Vivos Therapeutics chair and CEO Kirk Huntsman. “Dentists who are using this technology report migraine resolution in about 9 out of 10 migraine sufferers. Not only can this novel oral appliance technology bring relief from migraines, but it is also FDA cleared to treat patients with TMD, teeth grinding (known as bruxism), and many other conditions related to breathing and sleep disorders. We believe this novel technology’s potential is just starting to be realized, and are working to obtain additional FDA clearances for other chronic and debilitating health conditions. Importantly, we expect this high margin new product line will start contributing to Vivos’ revenue in the second half of this year as we seek to work our way towards cash flow positive operations.”

To view the full press release, visit https://ibn.fm/9LpNZ

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (OSA), Temporomandibular Joint Dysfunction (TMD), headaches, and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 33,000 patients worldwide by more than 1,750 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Patient results will vary. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children, as well as the Preventive Oral Device(R), known as the POD(R), for the treatment of TMD and/or bruxism (unconsciously teeth grinding) and the Vivos Sleep POD(TM), which is a mandibular advancement device for the treatment snoring and mild to moderate obstructive sleep apnea in adults. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in the energy and infrastructure industry focusing on cryptocurrency hosting and self-mining with a focus on Bitcoin, has become a sponsor of the Zed Run community; the community is made up of users engaged in Zed Run, a blockchain-based game utilizing NFTs to represent racehorses. The company announced plans to sponsor multiple rounds of community races, which are in-person rounds of Zed Run competition; the races feature some of the best and most talented players in the emerging field of blockchain-based gaming competing against each other. BlockQuarry is partnering with Warhorse Racing Club to sponsor the in-person rounds of Zed Run competition and create an unforgettable tournament experience for players. The tournaments are scheduled throughout April, with a final live event scheduled on May 10, 2023, in Las Vegas. As a sponsor, BlockQuarry will have a prominent presence during the tournament, including branding and messaging throughout series. “Zed Run is a game-changer in the world of blockchain-based gaming, and we are thrilled to be able to support the incredible work they are doing,” said BlockQuarry president and chair Alonzo Pierce in the press release. “At BlockQuarry, we are always looking for new and exciting ways to connect with our community and support innovation in the blockchain space. This investment into their grassroots movement is just the latest example of that commitment.”

To view the full press release, visit https://ibn.fm/UGEUi

About BlockQuarry Corp.

BlockQuarry is an energy and infrastructure company focused on cryptocurrency hosting and self-mining operations, with leased properties located within the southeast United States. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure. For more information about the company, visit www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at the annual Digestive Disease Week (“DDW”) conference. The conference will be held on May 6–9, 2023, in Chicago. The company will be reporting on the data gathered during its recent study, titled “PCS12852, A Novel 5-HT 4 Agonist Improves GCSI Symptom Scores and Gastric Emptying in Gastroparesis Patients.” According to the announcement, PCS12852 has been shown to be safe and efficacious in a phase 2 proof-of-concept trial in gastroparesis patients; it also improved both gastroparesis symptom scores and gastric emptying rate. Processa Pharmaceuticals chief development and regulatory officer Sian Bigora will present the results during a research forum session, titled “AGA Gastroparesis and Small Intestinal Dysmotility” and slated for the first day of the conference. “We continue to see encouraging results with our drug-development pipeline, and inclusion in the DDW conference as an oral presentation is important and continued validation for our Regulatory Science approach,” said Processa Pharmaceuticals president and CEO in the press release. “Since the FDA-approved gastroparesis drugs have severe safety limitations, the fact that PCS12852 is ready to move to a phase 2b trial given the positive safety and efficacy results in our proof-of-concept gastroparesis trial is a significant milestone. The company is diligently exploring strategies to advance or monetize the program. We look forward to a robust discussion of the data throughout the DDW conference, and to providing continued updates to our shareholders.”

To view the full press release, visit https://ibn.fm/GOm8U

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also increase the probability of FDA approval for its NGC drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship.

The Processa team has a track record of obtaining more than 30 approvals for indications across almost every division of FDA. Using its proven Regulatory Science Approach, the Processa team has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGCs are expected to include fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response and a greater number of patients — in excess of 200,000 for each NGC drug — who will benefit from each NGC drug. Currently under development are three next generation chemotherapy oncology treatments: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

STRATA Skin Sciences (NASDAQ: SSKN) is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC(R) excimer lasers, VTRAC(R) lamp systems, and now the TheraClear(R)X Acne Therapy System.

STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice. For more information, visit the company’s website at www.strataskinsciences.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

Investor Contact:
Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
[email protected]

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Onfolio Holdings (NASDAQ: ONFO, ONFOW) acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires business that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence and can be managed by our existing team or have strong management teams largely in place. The company excels at finding acquisition opportunities where the seller has not fully optimized their business, and Onfolio’s experience and skillset allows it to add increased value to these existing businesses. For more information, visit the company’s website at www.onfolio.com.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

AUM Biosciences is a global clinical-stage oncology company focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance. AUM is advancing a broad portfolio of precision oncology therapeutics. AUM001 is a selective and synergistic MNK inhibitor as shown in current studies and expected to be evaluated in a Phase 2 clinical trial in metastatic colorectal cancer with enrollment on track to commence in the first half of 2023. AUM601 is a promising Phase 2 ready therapy for Tropomyosin Receptor Kinase (“TRK”) fusions and mutations within the kinase domain and has received Orphan Drug Designation for the treatment of solid tumors with the NTRK fusion gene from the US FDA. AUM302 is a potentially first-in-class macrocyclic oral kinase inhibitor rationally designed small molecule to uniquely combine pan-PIM kinase, pan-PI3K and mTOR inhibition in a single agent, and has received Orphan Drug Designation for the FDA for the treatment of neuroblastoma, as well as Pediatric Review Designation. Comprised of pharma industry veterans with decades of research and development experience, the AUM leadership has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and has contributed to over 50 INDs and over 150 oncology clinical trials, and development of several currently marketed oncology treatments with annual peak sales up to $3 billion. For more information, visit the company’s website at https://aumbiosciences.com/.

To view IBN’s coverage of the conference, visit https://ibn.fm/EFHutton2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the Inaugural EF Hutton Global Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and its CEO Doug Drysdale will be spotlighted during the 26th annual Milken Institute Global Conference. The conference, slated for May 2, 2023, will be held in Beverly Hills California. Drysdale will be participating on a panel that will be addressing the topic “Progress and Innovation: The Dawning of a New Day in Treating Mental Health”; the panel will begin at 11:30 am. ET. The Milken Institute is a nonprofit, nonpartisan think tank dedicated to connecting resources and innovation so the best ideas can succeed. “Our work is focused on developing safe and effective psychedelic-based treatments for mental health conditions that are designed to achieve better clinical outcomes with fewer side effects for patients,” said Cybin CEO Doug Drysdale in the press release. “The Milken Institute Global Conference provides an ideal opportunity to engage with global thought leaders working to improve the mental health landscape and to share the innovative clinical work that Cybin is doing to address the significant unmet need for new treatment options for people suffering from these devastating conditions.”

To view the panel discussion, visit https://ibn.fm/KKuTB

To view the full press release, visit https://ibn.fm/319ln

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, has filed required information with the U.S. Securities and Exchange Commission regarding the 100% acquisition of issued and outstanding share of Tingo Foods PLC. Of note, the filing reflects that Tingo Foods began operations in September 2022 and by Dec. 31, 2022, had generated $466.2 million in revenue. Gross profit for that period totaled $196.4 million, equating to a gross margin of 42.1%. The report also reflect cash of $54.8 million and inventory valued at $201.1 million. According to the announcement, following the acquisition, Tingo Group is focused on revolutionizing Africa’s food-processing industry with strategic plans to develop a $1.6 billion food-processing facility, which will be the largest such facility in Africa. The filed information includes a current report on Form 8-K/A and an audit report from Deloitte (Brightman Almagor Zohar & Co., certified public accountants, a firm in the Deloitte global network). “We are delighted that Tingo Foods generated nearly a half billion dollars of high-margin revenues during its first four months of operations to December 31, 2022, and very excited to consolidate its results into our own beginning from the acquisition completion date of Feb. 9, 2023,” said Tingo Group CEO Darren Mercer in the press release. “The inclusion of these financials will have an immediate and significant impact on our group revenues and profitability. The recently announced pro forma consolidated financial information of Tingo and Tingo Mobile Limited, which reflected pro forma consolidated revenues of $1.152 billion and gross profit of $675 million, combined with today’s Deloitte audited results of Tingo Foods Plc for the four months to Dec. 31, 2022, demonstrates both the financial strength of the company and its impressive rate of growth.”

To view the full press release, visit https://ibn.fm/XTfkA

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device as a service” smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services including, among others, the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with 130-plus offices located in China’s cities and major town, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/TMNA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sidus Space (NASDAQ: SIDU), a Space-as-a-Service satellite company, announced the pricing of an underwritten public offering. The offering is comprised of 30,303,030 shares of its Class A common stock, or prefunded warrants in lieu thereof, and 30,303,030 warrants. According to the announcement, each share will be sold at a combined price of $0.33, with each warrant allowing the purchase of one share of Class A common stock. Anticipated gross proceeds from the offering will be an estimated $10 million before standard deductions. The company also noted that it has granted the underwriters a 45-day option to purchase additional shares — up to 4,545,454 shares and/or 4,545,454 additional warrants to cover any potential overallotments. According to the announcement, Sidus Space anticipates using the funds from the offering for sales and marketing, operational costs, product development and manufacturing expansion with any remaining proceeds dedicated to working capital and other general corporate purposes. Representatives of the underwriters for the offering are Boustead Securities LLC and EF Hutton, division of Benchmark Investments, LLC.

To view the full press release, visit https://ibn.fm/H77pT

About Sidus Space

Sidus Space, located in Cape Canaveral, Florida, operates from a 35,000-square-foot manufacturing, assembly, integration and testing facility focused on commercial satellite design, manufacture, launch and data collection. The company’s rich heritage includes the design and manufacture of many flight and ground component parts and systems for various space-related customers and programs. Sidus Space has a broad range of Space-as-a-Service offerings including space-rated hardware manufacturing, design engineering, satellite manufacturing and platform development, launch and support services, data analytics services and satellite constellation management. Sidus Space has a mission of Bringing Space Down to Earth(TM) and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. Any corporation, industry or vertical can start their journey off-planet with Sidus Space’s rapidly scalable, low-cost satellite services, space-based solutions and testing alternatives. More than just a Satellite-as-a-Service provider, Sidus Space is a trusted mission partner, from concept to Low Earth Orbit and beyond. For more information, please visit www.SidusSpace.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced it is extending its partnership with Michigan Works! Southeast (“MWSE”), a longtime leader in upskilling the workforces of Southeast Michigan. The continued partnership will deliver upskilling needs, specifically training on artificial intelligence technologies for the Michigan workforce on MWSE’s proprietary Learning Community Environment(R) – powered by Amesite. “The emergence of ‘new collar’ jobs is a result of the power of artificial intelligence to increase the capabilities of all workers,” said Shamar Herron, executive director, Michigan Works! Southeast. “In collaboration with Amesite, we are preparing our constituents to seize these skills-driven opportunities, by upskilling them in cutting-edge work practices.”

To view the full press release, visit https://ibn.fm/EUCv4

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Athlete Studio, the No. 1 eCommerce platform for athletes and sports brands, is partnering with SportsCast to launch a new series of digital collectibles with exclusive content. According to the announcement, the collaboration enables Athlete Studio to utilize SportsCast’s cutting-edge technology and riveting content to power its proprietary digital collectible series. SportsCast is a leading provider of unique sports media collectibles, including digital cards that unlock exclusive athlete content and VIP experiences. The first offering from the partnership will include a free SportsCast “bite” digital collectible featuring a video trailer of Eddie George interviewing running back Jerome Bettis; George is a Heisman Trophy-winning running back. Upcoming offerings will include additional exclusive content, merchandise and VIP experiences. Athlete Studio and SportsCast are committed to providing sports fans and collectors with unique experiences that cannot be found or owned anywhere else. “We are thrilled to partner with SportsCast to launch our digital collectible and exclusive content series,” said Athlete Studio CEO Nicholas Lemieux in the press release. “SportsCast’s cutting-edge technology and commitment to providing high-quality sports content aligns perfectly with our vision of providing unique experiences.”

In addition, Lemieux is also featured in the latest episode of The Bell2Bell Podcast. IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, announced the release of the new offering. The Bell2Bell Podcast is designed to deliver informative updates and exclusive interviews with executives of companies operating in fast-moving industries. During the episode, Lemieux discusses the purpose of the company — to address specific issues facing sports figures and athletes who want to connect with their fans and be able to market goods and collectibles. He also talked about the company’s growth, starting as a small startup with two employees to its current staff of 24 full-time employees. “The initial idea for Athlete Studio was to build content-based automation software for API-based content automation software, using data from ESPN, social media platforms or YouTube to automate the creation of websites, email newsletters and other tedious marketing tasks that every influencer and athlete has to do manually,” said Athlete Studio founder and CEO Nicholas Lemieux during the podcast. “That led to us, over time, focusing the platform 100% on sports and athletes. Today, Athlete Studio is the number one eCommerce platform for professional athletes. We actually license the platform to sports agencies who provide the automation of personal branding, websites and eCommerce to help their athletes build their personal brands and generate revenue off the field.”

To view the full press releases, visit https://ibn.fm/NItuG and https://ibn.fm/embQa

About Athlete Studio

Athlete Studio creates eCommerce and marketing software for pro athletes and sports brands. The platform helps athletes such as Justin Jefferson, Jalen Hurts and Angele Reese automate  the creation of their personal brands, custom merchandise and digital collectibles. Sports brands partner with Athlete Studio to engage pro athletes and leverage Athlete Studio’s Web3 technology to increase customer loyalty. For more information, please visit www.Athlete.Studio.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has closed on a private placement of secured convertible debentures. According to the company, the private placement resulted in gross proceeds of AUD$2.4 million, which represents an oversubscription of AUD$400,000 above its previously announced minimum placement of AUD$2,000,000. The announcement noted that Westar Capital Limited acted as lead manager for the private placement. The company anticipates using the funds from the placement to advance its research and development programs and for general working capital purposes. The announcement also specified that the closing of the private placement is dependent on Canadian Securities Exchange approval and that the issued securities will be subject to a four-month-plus-one-day hold period in accordance with applicable laws.

To view the full release, visit https://ibn.fm/fU9zg

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has initiated a phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida, where an interim analysis showed an average reduction in binge eating episodes of greater than 80%. The company is also planning for phase 2a clinical trials with the University of Michigan for the treatment of fibromyalgia and with Mass General Hospital for the treatment of abdominal pain related to irritable bowel syndrome. Each of the studies are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit is demonstrated, subsequent studies are expected to utilize TRP-8803 (IV-infused psilocin), which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a company focused on building infrastructure on the Bitcoin Lightning Network global micropayment system, has closed on its previously announced nonbrokered private placement. The private placement, which was announced earlier this month, closed for an estimated $300,000 gross proceeds and comprised the issuance of 468,750 units of the company for $0.64 per unit; each unit included one common share of the company and one common share purchase warrant, with each warrant being exercisable for one common share at an exercise price of $0.85 per common share at any time up to 36 months following the private placement closing. According to the announcement, the funds from the private placement will be used to expand LQwD’s Lightning Network business as well as general working capital purposes.

To view the full press release, visit https://ibn.fm/mnw2j

About LQwD Fintech Corp.

LQwD is a Lightning Network service provider (“LSP”) focused on developing payment infrastructure and solutions accelerating the global megatrend of Bitcoin adoption through the Lightning Network. The company’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling Bitcoin. LQwD also holds Bitcoin that is used as an operating asset establishing nodes and payment channels on the Lightning Network. For more information, please visit www.LQwDFintech.com.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and other diseases, announced been “allowed” a key patent by the European Patent Office (“EPO”). According to the announcement, the patent protects the use of “lower specific activity” Samarium-153 in conjunction with the treatment of bone cancer in children and adults. The company noted that the new patent in Europe covers the “high purity therapeutic bone agents” technology that is licensed worldwide exclusively to QSAM. The process enables streamlined manufacturing, lower costs and logistical advantages for the company, along with the significant reduction of long-lived impurities, namely Europium-154, which show potential for higher and multiple dosing regimens in the treatment of different types of bone cancer, including those that are the focus of QSAM’s current FDA-cleared phase 1 clinical trial. “We believe that repeated dose regimens of CycloSam may be the key to being able to successfully treat bone tumors, and we are continuing to advance our clinical trials program to generate data toward that goal,” said QSAM Biosciences DEO and cofounder Douglas R. Baum in the press release. “This allowance by the EPO marks our second patent in Europe, and we expect to register the patent in multiple individual countries in the EU over the following few weeks, thereby expanding our already established and robust patent estate. More so, this additional IP protection broadens our potential commercial market for what we believe may eventually be a breakthrough therapy for both primary and secondary forms of bone cancer.”

To view the full press release, visit https://ibn.fm/RL6He

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and related diseases. QSAM’s initial technology, CycloSam (Samarium-153 DOTMP), is a clinical-stage, bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space that also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product. The QSAM team has designed the CycloSam product with the goal of overcoming the limitations of the Quadramet(R) (Samarium-153 EDTMP) product and potentially expand the FDA-approved indications. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. CycloSam has demonstrated preliminary safety and efficacy in animal studies and a single-patient, FDA-cleared human trial performed in 2020 at the Cleveland Clinic. This nuclear technology uses low specific activity Samarium-153 (resulting in far less undesirable europium impurity) and DOTMP, a chelator believed to reduce or eliminate off-target migration and targets sites of high bone turnover, making it, in management’s opinion, an ideal agent to treat primary and secondary bone cancers. Since CycloSam delivers targeted radiation selectively to the skeletal system, it is also believed to be a great potential candidate for future effectiveness in clinical trials in bone marrow ablation as preconditioning for bone marrow transplantation as well as its future clinical trials in procedures to reduce external beam radiation to bone tumors. This multipatented drug candidate utilizes a radioisotope previously approved by the FDA, combined with a novel targeting chelant, DOTMP, that has demonstrated preliminary increased efficacy and decreased side effects in animal models and veterinary treatment of bone cancer in dogs. Further, CycloSam utilizes a streamlined, just-in-time manufacturing process that is already in place. Given these factors, management believes there is a strong pathway to commercialization for CycloSam. For more information about the company, please visit www.QSAMBio.com

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced the appointment of F. William (Bill) Caple to its board of directors. Caple brings over 30 years of experience in investment banking, specifically with M&A and capital raises, management consulting and entrepreneurship. “We are thrilled to welcome Bill to our board of directors,” said Robert Nistico, CEO and chairman of Splash Beverage Group. “His wealth of experience and success in corporate finance strategies and M&A, business development, sales and marketing will be invaluable to our company’s growth initiatives, and we look forward to his contributions. Bill rounds out our board perfectly as each member brings a top-tier level of expertise in every key subject to help guide us as we continue to grow.”

To view the full press release, visit https://ibn.fm/NdQcg

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries, today provided a progress update on its April 21, 2023, announcement. On that day, the company announced its strategic decision to offer up to five exclusive statewide THC-processing licenses to its revolutionary, patented UltraShear Technology(TM) (UltraShear(TM) or UST(TM)) platform for the preparation of oil-soluble THC concentrates into long-term stable, effectively water-soluble, and highly bioavailable nanoemulsions of THC oil in water. “Completing the sale of these five licenses is expected to generate $5,000,000 or more of topline, non-dilutive revenue for PBIO,” said Richard T. Schumacher, CEO and president of PBI. “These funds will facilitate our rapid production of UltraShear equipment, which will support these THC processing licenses, as well as efforts underway to develop multiple other Nano products to serve additional major potential markets, such as sleep, immune booster and hair restoration. Many of these additional markets are multiples in size of the THC opportunity, which is already a major market opportunity.”

To view the full press release, visit https://ibn.fm/kg4CJ

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. Pressure BioSciences’ patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. Pressure BioSciences has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM) or UST(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, has entered into a tri-partite agreement with Prime Commodity Exchange (“PCX”) and All Farmers Association of Nigeria (“AFAN”). According to the announcement, the three companies have been given a three-decade lease over AFAN’s existing network of warehouses, which currently number 2,322, along with an agreement to increase the number of warehouses in the network to 80,000 during the next two years. These warehouses are typically used for storing crops and agricultural produce for its farmers. The agreement calls for PCX to install its leading-edge e-Warehouse Receipt System (“eWRS”) in all warehouses, which enables crops and other produce to be commoditized and traded by Tingo from the date of delivery; the agreement also gives Tingo Mobile the right of first refusal to purchase or trade all produce stored in the warehouses. The agreement positions TIO to monetize Nigeria’s crop ecosystem across the country as well as in the global export market. “Today’s agreement further strengthens our already strong relationship with AFAN and solidifies our position as Africa’s leading agri-fintech business,” said Tingo Mobile and Tingo Foods founder Dozy Mmobuosi in the press release. “In addition, we are thrilled to embark on a relationship with PCX, which we consider to be a valuable technology partner, in particular, through the supply of their eWRS system and their Prime Commodity Exchange trading platform. The components of today’s agreement further augment our seed-to-sale model and enhance the financial upliftment and empowerment of our farmers. Furthermore, we believe our improved ability to handle and store inventory will further assist us to achieve our objective of reducing post-harvest losses and crop wastage, while also increasing food production levels and meaningfully improving food security.”

To view the full press release, visit https://ibn.fm/1mSlK

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device as a service” smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services including, among others, the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with 130-plus offices located in China’s cities and major town, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/TMNA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Lottery.com (NASDAQ: LTRY), a leading provider of lottery results data servicing global publishers, search engines, and voice assistants, has resumed ticket sales operations to support its affiliate partners through its Texas retail network. According to the announcement, Lottery.com provided more than seven million tickets for Texas lottery games in its first week of operation after starting operations again. The company also signed an exclusive affiliate agreement with International Gaming Alliance (“IGA”); the agreement enables Lottery.com to offer official Texas lottery tickets in the Dominican Republic. IGA has an established retail and online distribution network in the Dominican Republic with access to more than 1,000 retail distribution points. According to the announcement, Lottery.com anticipates beginning to provide tickets sometime next month. “We are making great progress as a company, and it is testament to the resilience of both our operational alacrity and our people that we were able to fulfill this order in such a short time frame, after almost nine months of shut down,” said Lottery.com CEO Mark Gustavson in the press release. “We are now up and running again and able to supply tickets. Our production capacity through our retail partner network has tripled, and all machines and personnel capacity has been ramped up to supply our customers. These will include our new agreement with IGA in the Dominican Republic, and we hope to announce further deals in due course. Since my arrival, regaining compliance with the NASDAQ Listing Rules has been an absolute priority. In this regard, the new management team is working with our auditors and other advisers to substantially improve our disclosure and reporting controls, as well as implementing an overhaul of our systems of internal control. Our business turnaround is working to plan, and we [are] optimistic about the future prospects for the business.”

To view the full press release, visit https://ibn.fm/9GE4q

About Lottery.com Inc.

Lottery.com, Inc. is a leading technology company that is transforming how, where and when lotteries are played. Its engaging mobile and online platforms enable players and commercial partners located throughout the United States and other countries to remotely purchase safe and legally sanctioned lottery games. Lottery participants look to the Company’s website, Lottery.com, for compelling, real-time results on over 800 lottery games from over 40 countries. Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the Southeast United States, today released its financial and operational highlights for the 2022 calendar year. “I am extremely grateful for what we were able to accomplish as a company in 2022. It was a year of growth and learning for all, and we were able to take a lot from the good and the bad,” said Alonzo Pierce, president and chair of BlockQuarry. “Our strongest line item by far in the financials was our 520% increase in YOY revenue compared to 2021. That is something that we are extremely proud of as we continue to diversify our business operations to try to increase that number in the coming years.”

To view the full press release, visit https://ibn.fm/0v3zr

About BlockQuarry Corp.

BlockQuarry is an energy and infrastructure company focused on cryptocurrency hosting and self-mining operations, with leased properties located within the Southeast United States. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork